Quantum Cyber profile
Quantum Cyber is a Nasdaq-listed company that rebranded from a colorectal-cancer diagnostics business into a multi-domain autonomous-defense platform during 2026. The pivot has been funded mostly through stock-based licensing and acquisition deals rather than product revenue.
What Quantum Cyber does
Quantum Cyber traded until March 2026 as Mainz Biomed, a business that sold colorectal-cancer screening tests, and reports no revenue from continuing operations in its current filings. The model today is built largely from licensed technology and acquired facilities, not engineering built up in-house over years. Shareholders approved the rename to Quantum Cyber and a new Nasdaq ticker, QUCY, on April 22, 2026. Within two months the company had licensed an exclusive, worldwide drone-technology portfolio from a Miami engineering shop called BP United. It also licensed separate quantum-photonic antenna technology from Project LightShift, and closed on a roughly 50,000-square-foot manufacturing building in Bridgeport, Connecticut. Both technology licenses were paid mostly in Quantum Cyber stock rather than cash. SEC filings show the BP United deal alone added 20 million restricted shares to the company's share count. Those shares were recorded at $5.47 million, on top of $1 million in cash. That combination, licensing someone else's engineering and paying largely in equity, is the detail investors should track most closely. The manufacturing capacity is real and now sits inside a Connecticut warehouse. The underlying drone designs originated outside the company. Each new deal spreads the same business across more shares outstanding.
The product lines that define the company for research purposes:
- Attritable one-way-attack drones
- Interceptor drones, including the completed mini-interceptor prototype
- Surveillance drones
- VTOL drone line
- PHANTOM-950 long-range drone
- Advanced Filament Manufacturing Division (standard PETG and "Formula A" EMP-hardened composite filament)
This profile is qualitative by design. It carries no share price, no price target, no valuation multiple, and no rating — those change faster than any page can honestly track, and the filings linked below are the authoritative source for them.
Quantum Cyber drone lineup
The current public product record does not identify a complete aircraft lineup.
No complete-aircraft offering is catalogued for this company; it is tracked here as an unmanned-systems enabler.
Statuses are editorial classifications from the company’s current public catalog: active means currently presented for sale, delivery, or program work; development means publicly disclosed but not a mature production offering; legacy means retained for historical or installed-fleet coverage.
Recent contracts & awards
A dated log of the specific contracts, orders, funding, and deployments reported for Quantum Cyber, each tied to its primary source. This is a record of what was announced — a "selection", "award", or "partnership" is not the same as obligated money, so read each source before treating a figure as revenue. No figure appears here unless a source reported it.
- Quantum Cyber completes purchase and installation of 80-unit 3D-printing drone production farm at Bridgeport, Connecticut facility
Quantum Cyber announced it finished buying and installing 80 3D-printing units at its roughly 50,000-square-foot Bridgeport, Connecticut facility, calling it the primary autonomous drone manufacturing line for planned attritable one-way-attack, interceptor, surveillance, VTOL, and long-range PHANTOM-950 drone lines. The printers use standard PETG and a patent-pending EMP-hardened filament called Formula A, made in-house through the company's Advanced Filament Manufacturing Division. The release does not disclose any procurement contract tied to the installation.
Quantum Cyber (GlobeNewswire): Completes Purchase and Installation of 80-Unit 3D Printing Drone Production Farm - Quantum Cyber's Q2 2026 Form 10-Q discloses going-concern doubt and a $121 million accumulated deficit
Quantum Cyber's quarterly report for the period ended June 30, 2026 disclosed cash of roughly $13.4 million, a $16.1 million net loss for the six-month period, and an accumulated deficit near $121 million carried over largely from the company's prior diagnostics business. The filing states that these conditions raise substantial doubt about the company's ability to continue as a going concern, standard disclosure language triggered once losses and cash position cross a defined threshold.
Quantum Cyber Form 10-Q, quarter ended June 30, 2026 (SEC EDGAR) - Quantum Cyber completes its first mini-interceptor drone at the Bridgeport, Connecticut facility
Quantum Cyber said it assembled its first mini-interceptor prototype, described as reaching up to 220 kilometers per hour with roughly 20 minutes of flight time and up to 50 grams of energetic payload, designed for swarm deployment in groups of up to 12 units per airborne sentinel platform. The announcement covers one completed unit; no serial-production count or delivery contract was disclosed.
Quantum Cyber (GlobeNewswire): Completes First Mini-Interceptor Drone at Its Newly U.S. Manufacturing Facility - Quantum Cyber secures exclusive drone-technology license from BP United
Quantum Cyber announced an exclusive, worldwide license to BP United's drone technology portfolio, including an autonomous sky-defense platform BP United calls Sky Guard, rated for ranges beyond 25 kilometers with autonomous takeoff, navigation, and landing. Quantum Cyber's later SEC filings disclose the license was paid for with $1 million in cash and 20 million restricted shares, recorded at $5.47 million; BP United is required to establish a commercial supply arrangement for production and delivery.
Quantum Cyber (GlobeNewswire): Secures Exclusive Autonomous Drone Platform
Where Quantum Cyber sits in the value chain
Quantum Cyber is a pure-play: unmanned systems are the business rather than one line inside it, so the P&L moves with drone demand and has little else to cushion a slow procurement year.
Its disclosed activity spans aerial drones, counter-UAS, maritime autonomy. That placement is the single most useful thing to fix in your head before reading any coverage, because the same headline means different things at different layers: a large platform award is transformative for a pure-play, material but diluted for a diversified contractor, and only indirectly relevant to a component supplier whose exposure arrives later as build-rate demand. Retail coverage routinely applies one story to all three layers at once. For the layer-by-layer comparison across the sector, see the drone stocks research shortlist and the list of publicly traded drone companies.
A Diagnostics Company Became a Drone Manufacturer in Five Months
Quantum Cyber's own corporate history is the first thing a researcher has to hold in mind. Almost nothing about the current business predates 2026. As Mainz Biomed, the company spent years selling ColoAlert, a colorectal-cancer screening test. It traded at a market capitalization under $10 million in early 2026. In March 2026, the board brought in Robert Liscouski, a former U.S. Department of Homeland Security assistant secretary for infrastructure protection, as chairman. The company announced a pivot toward quantum computing and cybersecurity under the Quantum Cyber name. That strategy shifted again within weeks. By May 2026, the company had licensed drone technology from BP United instead of building a cybersecurity product line. By July, it had assembled a single mini-interceptor prototype at a newly purchased Connecticut facility. Five months separate a cancer-diagnostics company from a drone manufacturer with an installed 80-unit 3D-printing line. That pace cuts against the "quantum-accelerated" framing the company uses in its own materials. The underlying drone designs and the photonic technology it has licensed both originated at outside firms, not inside a Quantum Cyber engineering program built over time. The technical foundation is only as durable as those license agreements. A funded government contract, a second and third completed drone, or an independent design review would show the manufacturing operation works on its own. Announcement volume alone is not that evidence.Installed Printers Do Not Yet Equal Delivered Drones
The Bridgeport facility and its 80-unit 3D-printing farm are verifiable capital assets. SEC filings and the company's own newsroom describe a roughly 50,000-square-foot building acquired in July 2026. Alongside it sits an in-house Advanced Filament Manufacturing Division, meant to supply both standard PETG and a patent-pending EMP-hardened filament called Formula A. Management has also stated a target of approximately 100,000 drones per year once the line is fully operational. No disclosed order book or procurement contract sits behind that figure. It is a projection, not a backlog number. Treating it as booked demand would be a mistake a careful reader of the filings would not make. For comparison, trade coverage has noted that an established counter-UAS vendor like Anduril already holds a large, multi-year U.S. Army contract. That same coverage reported interceptor speeds above Quantum Cyber's stated 220 kilometers per hour for its mini-interceptor. The comparison is not proof Quantum Cyber cannot compete. It is a reminder that installed manufacturing capacity and a completed prototype are earlier-stage signals than a fielded system already under contract. A second and third completed interceptor, tested against a published performance figure, would close that gap; another facility or licensing announcement would not.Stock-Based Licensing Deals Are Diluting Shareholders Before Any Revenue Arrives
Quantum Cyber's own June 2026 investor presentation described a "$15 million debt-free balance sheet." The same release cited eight filed patent applications and letters of intent it associated with SOCOM and a person the release referred to as "General Cherry." Two months later, the company's Form 10-Q for the quarter ended June 30, 2026, told a more cautious story in the language regulators require. That filing discloses cash of roughly $13.4 million. It also reports an accumulated deficit near $121 million, carried over largely from the diagnostics-era losses, and a $16.1 million net loss for the six-month period. The filing states plainly that these conditions "raise substantial doubt about the Company's ability to continue as a going concern." Neither statement is false. A presentation built to sell the story and a quarterly filing built to satisfy disclosure law are different documents with different purposes. Reading only one of them gives a distorted picture. Shares outstanding also grew through the year, since licensing and acquisition deals were paid partly in stock rather than cash. Each new headline can add to share count even when it adds nothing to revenue in the same period. A reader weighing Quantum Cyber's pivot should read the going-concern sentence in the quarterly filing at least as closely as the balance-sheet framing in the investor deck.What to watch
The signals worth tracking are structural, not price-based — they tell you whether the business is changing shape, which is what eventually shows up in the numbers.
- Whether the 80-printer installation at Bridgeport turns into repeatable serial production. The company's own announcements report one completed mini-interceptor prototype and no second finished unit as of this entry.
- Whether any of Quantum Cyber's announced letters of intent, including one it describes as covering U.S. Special Operations Command (SOCOM), convert into a funded, obligated contract. A letter of intent is not a purchase order. The company's SEC filings report no contract revenue from continuing operations.
- Share count and dilution. The BP United and LightShift technology licenses were paid mostly in restricted stock. Any future deal Quantum Cyber structures the same way adds shares without adding revenue in the same filing period.
- Whether the going-concern language in the company's own SEC filings gets removed in a later quarter or repeated. That single sentence is the most direct signal of how much runway the pivot actually has.
- How Quantum Cyber's mini-interceptor specifications hold up once more performance detail is disclosed. A company this early in production has an incentive to lead with best-case figures rather than tested ones.
- Whether the Securities and Exchange Commission's own industry classification for the company ever gets updated. As of its most recent quarterly filing, it is still listed as pharmaceutical preparations, a leftover from the diagnostics era.
How to research Quantum Cyber
Every question below has one authoritative source, and using the wrong source is how most retail research goes wrong.
| Research question | Where the answer lives | What to look for |
|---|---|---|
| How much of this is really drones? | Segment tables in the annual filing | Whether unmanned systems are reported as their own segment or buried inside a larger one. |
| Is the revenue repeatable? | Revenue-recognition policy and backlog discussion | Recurring sustainment, services, or subscription language versus one-time hardware sales. |
| Is a win real money? | Official DoD contract announcements | Contract type, awarding command, and whether the amount announced is obligated or a ceiling. |
| Can the balance sheet fund the plan? | Liquidity discussion and share-count disclosure | Dilution history and cash runway relative to the manufacturing scale-up being promised. |
- The Form 10-Q for the quarter ended June 30, 2026, filed on SEC EDGAR, is the primary source for the numbers on this page: a $121 million accumulated deficit, a $16.1 million six-month net loss, $13.4 million in cash, and management's own statement that results "raise substantial doubt about the Company's ability to continue as a going concern."
- The full EDGAR filing history for CIK 1874252 is filed under all three of the company's names, Mainz Biomed B.V., Mainz Biomed N.V., and Quantum Cyber N.V., and is the fastest way to see exactly when the diagnostics business ended and the defense-platform business began.
- Quantum Cyber's own press releases, distributed on GlobeNewswire, are the primary source for each production milestone described here; verify dates and quoted figures against the SEC filing above rather than a wire summary.
- The July 27, 2026 mini-interceptor announcement is on GlobeNewswire, and the May 13, 2026 BP United licensing announcement is on GlobeNewswire as well.
- BP United's own site describes the Sky Guard autonomous platform that is the basis of the exclusive license Quantum Cyber holds; Quantum Cyber's current drone lines are downstream of that licensed design work rather than a Quantum Cyber engineering program that predates 2026.
- Independent trade coverage from DroneXL lays out the pivot timeline in detail and is the source for the comparison against fielded counter-UAS interceptor speeds referenced in the analysis below; read it alongside the company's own releases rather than in place of them.
- For how Quantum Cyber's counter-UAS ambitions compare to an established fielded vendor, see the Anduril profile on this site.
One failure mode is worth naming explicitly: a company announcement describing a "selection", "award", or "partnership" is not the same as obligated money, and the two are easy to conflate because they use the same vocabulary. Check the filing before treating either as revenue. Our full approach is documented on the methodology page.
Quantum Cyber FAQ
What does Quantum Cyber do?
Quantum Cyber traded until March 2026 as Mainz Biomed, a business that sold colorectal-cancer screening tests, and reports no revenue from continuing operations in its current filings.
Is Quantum Cyber publicly traded?
Quantum Cyber trades as QUCY on NASDAQ. Listing status is not a quality signal, and nothing here is a recommendation to buy or sell it.
What should investors watch with Quantum Cyber?
Whether the 80-printer installation at Bridgeport turns into repeatable serial production. The company's own announcements report one completed mini-interceptor prototype and no second finished unit as of this entry.
Where can I research Quantum Cyber directly?
Go to the primary sources: Quantum Cyber corporate site, Quantum Cyber SEC filings (EDGAR, CIK 1874252), Quantum Cyber Form 10-Q, quarter ended June 30, 2026. Avoid aggregator summaries when the filing itself is available.
Is Quantum Cyber the same company that used to be called Mainz Biomed?
Yes. Quantum Cyber N.V. is the same SEC-registered entity, filed under CIK 1874252, that traded as Mainz Biomed N.V. and, before that, Mainz Biomed B.V. Shareholders approved the name change and a new Nasdaq ticker, QUCY, on April 22, 2026. New leadership steered the company first toward quantum computing and cybersecurity, then toward drone manufacturing. Mainz Biomed's colorectal-cancer screening business is not disclosed as an ongoing revenue source in the company's most recent quarterly filing.
Has Quantum Cyber delivered drones under a government contract?
Not as of its most recent public filings. The company has completed one mini-interceptor prototype, announced in July 2026. It has also referenced non-binding letters of intent, including one it describes as covering U.S. Special Operations Command (SOCOM). A letter of intent and a prototype are not the same thing as a funded, obligated purchase order. No Department of War contract announcement naming Quantum Cyber had been published as of this writing.
What is BP United, and why does its name show up in Quantum Cyber's drone story?
BP United is a privately held autonomous-vehicle engineering company based in Miami, Florida. In May 2026 it granted Quantum Cyber an exclusive, worldwide license to its drone technology portfolio, including a platform BP United calls Sky Guard. The deal paid BP United $1 million in cash and 20 million shares of Quantum Cyber stock. Quantum Cyber's drone lines are built on that licensed design work, not on an engineering program the company ran itself before 2026.
Does Quantum Cyber's stock carry going-concern risk?
Yes, by the company's own admission. Its Form 10-Q for the quarter ended June 30, 2026, filed with the SEC in August 2026, points to recurring losses and an accumulated deficit near $121 million. The filing states that these conditions "raise substantial doubt about the Company's ability to continue as a going concern." That is standard disclosure language, required once losses and cash position cross a certain threshold. It means the balance sheet and cash-runway numbers in that filing deserve a direct read, rather than reliance on summarized coverage.
Related coverage
- Company directory
- Drone stocks hub
- Defense stocks hub
- Military drone stocks
- How to buy drone stocks
- Defense and drone ETFs